Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.00%
)
US TECH 100
24,022.00
(
-0.46%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
104.78
(
4.10%
)
Bitcoin
72,418.43
(
-2.05%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: srsmgja post# 81075

Tuesday, 07/28/2009 1:46:05 AM

Tuesday, July 28, 2009 1:46:05 AM

Post# of 257253
Copaxone vs Tysabri in the US Market 
 
       Tysabri    Copaxone  
      sales ($M) sales ($M)  
 2Q09    125        438  
 1Q09    116        430  
 4Q08    115        384  
 3Q08    122        352
The cumulative growth of US Tysabri sales during the past three quarters has been 2.5%.

The cumulative growth of US Copaxone sales during the past three quarters has been 24.4%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today